MERRIMACK PHARMACEUTICALS IN (MACK) Stock Analyst Earnings Estimates
NASDAQ:MACK - Nasdaq - US5903282094 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 102.8M | 96.312M -100.00% | 139.59M | N/A | N/A | N/A | N/A | N/A | N/A | ||
| EBITDA YoY % growth | -63.08M | -106.182M -124.87% | -125.46M 3.63% | -99.96M 33.81% | N/A 32.00% | N/A 67.06% | N/A 75.83% | N/A | N/A | N/A | |
| EBIT YoY % growth | -66.3M | -121.653M -118.85% | -109.35M 2.41% | -83.346M 32.42% | N/A 31.45% | N/A 65.70% | N/A 78.22% | N/A 46.94% | N/A 19.23% | N/A -3.62% | |
| Operating Margin | -64.49% | -126.31% | -78.34% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -8.00 | -12.53 -65.00% | -11.78 8.33% | 37.01 30.17% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -0.03 25.00% | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |